Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94121


Purpose:

This study aims to determine whether or not gadoxetate disodium (Eovist) enhanced magnetic resonance imaging (MRI) has a higher sensitivity for detecting hepatocellular carcinoma (Liver Cancer) comparison to multi-detector computed tomography (CT).


Criteria:

Inclusion Criteria: - Alpha-feto protein > 400 ng / mL or - prior ultrasound with mass suspicious for hepatic malignancy or. - clinical risk of hepatocellular carcinoma or - prior multi-detector CT with mass suspicious for possible hepatocellular carcinoma Exclusion Criteria: - Glomerulo-filtration rate < 50 mL/ min/1.73 m2 based on a creatinine measurement within three months of the MR study - Previous diagnosis of hepatic malignancy - Any conditions that would discount the ability to have an MRI scan


NCT ID:

NCT01341132


Primary Contact:

Principal Investigator
Rizwan Aslam, MD
San Francisco VA Medical Center


Backup Contact:

N/A


Location Contact:

San Francisco, California 94121
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.